Paragon 28 Price To Sales Ratio Over Time
| FNA Stock | USD 9.86 0.18 1.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Paragon 28 Performance and Paragon 28 Correlation. Paragon |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Paragon 28. If investors know Paragon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Paragon 28 listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share 2.95 | Quarterly Revenue Growth 0.181 | Return On Assets (0.08) | Return On Equity (0.34) |
The market value of Paragon 28 is measured differently than its book value, which is the value of Paragon that is recorded on the company's balance sheet. Investors also form their own opinion of Paragon 28's value that differs from its market value or its book value, called intrinsic value, which is Paragon 28's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Paragon 28's market value can be influenced by many factors that don't directly affect Paragon 28's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Paragon 28's value and its price as these two are different measures arrived at by different means. Investors typically determine if Paragon 28 is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Paragon 28's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare Paragon 28 and related stocks such as Pulmonx Corp, Iradimed, and Orthofix Medical Price To Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LUNG | 40.6952 | 40.6952 | 40.6952 | 40.6952 | 40.6952 | 40.6952 | 40.6952 | 40.6952 | 40.6952 | 42.7235 | 75.263 | 23.9316 | 5.8277 | 7.0502 | 6.7 |
| IRMD | 13.418 | 13.418 | 13.418 | 9.0933 | 7.2057 | 9.7621 | 3.6953 | 6.983 | 9.7314 | 6.8483 | 8.715 | 13.644 | 6.6676 | 9.1251 | 9.61 |
| OFIX | 4.407 | 1.1086 | 1.6144 | 1.0653 | 1.3793 | 1.8587 | 1.6019 | 2.2844 | 2.1427 | 1.8979 | 2.0369 | 1.318 | 0.8936 | 0.6631 | 0.63 |
| NPCE | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 16.0866 | 14.4575 | 5.4553 | 0.8051 | 4.0741 | 3.87 |
| ITGR | 0.8439 | 1.7176 | 1.7176 | 1.7176 | 1.7176 | 1.7176 | 2.0109 | 2.0109 | 2.0858 | 2.0858 | 2.4842 | 2.3126 | 1.648 | 2.0676 | 2.18 |
| GKOS | 25.5261 | 25.5261 | 25.5261 | 37.0911 | 17.0424 | 6.0172 | 9.8729 | 5.5375 | 10.8458 | 8.5859 | 14.8865 | 7.0169 | 7.3264 | 12.2333 | 14.85 |
| KIDS | 6.0373 | 6.0373 | 6.0373 | 6.0373 | 6.0373 | 4.6577 | 3.8717 | 2.0263 | 7.6157 | 9.4717 | 10.4793 | 11.7635 | 6.7266 | 4.9564 | 5.41 |
| CNMD | 0.372 | 1.0 | 1.0311 | 1.5569 | 1.6773 | 1.6938 | 1.6085 | 1.7881 | 2.0999 | 3.3165 | 3.7116 | 4.0905 | 2.5469 | 2.6981 | 2.83 |
| LIVN | 21.599 | 8.9057 | 7.5902 | 6.7305 | 6.7305 | 5.374 | 1.8101 | 3.8053 | 4.0071 | 3.3637 | 3.4439 | 4.2755 | 2.9065 | 2.4193 | 2.3 |
| SGHT | 143 | 143 | 143 | 143 | 143 | 143 | 143 | 143 | 143 | 67.1009 | 56.6814 | 17.0491 | 8.1905 | 3.0957 | 2.94 |
| SIBN | 1.0259 | 1.0259 | 1.0259 | 0.9371 | 1.3365 | 11.7299 | 7.376 | 5.7979 | 5.9979 | 7.8926 | 11.8396 | 8.1659 | 4.3713 | 5.8076 | 4.82 |
| VREX | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 1.3729 | 0.5997 | 0.5997 | 0.5997 | 0.979 |
| BRKR | 24.8591 | 1.2437 | 1.4122 | 1.7896 | 1.82 | 2.514 | 2.1215 | 3.0726 | 2.4531 | 3.8167 | 4.1779 | 5.2541 | 4.0134 | 3.6288 | 5.18 |
| CVRX | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 86.3443 | 89.2543 | 19.1381 | 16.7688 | 16.6056 | 15.78 |
Paragon 28 and related stocks such as Pulmonx Corp, Iradimed, and Orthofix Medical Price To Sales Ratio description
Price to Sales Ratio is figured by comparing Paragon 28 stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Paragon 28 sales, a figure that is much harder to manipulate than other Paragon 28 multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
| Paragon 28 | FNA |
| Classification | Medical Equipment |
| Location | Colorado; U.S.A |
| Exchange | New York Stock Exchange |
USD 9.86
Check out Paragon 28 Performance and Paragon 28 Correlation. For information on how to trade Paragon Stock refer to our How to Trade Paragon Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Paragon 28 technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.